91 related articles for article (PubMed ID: 33707407)
21. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
23. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell endometrial cancer.
Richey DS; Welch BJ
South Med J; 2008 Dec; 101(12):1266-8. PubMed ID: 19005452
[TBL] [Abstract][Full Text] [Related]
24. Parathyroid carcinoma: molecular therapeutic targets.
Marini F; Giusti F; Palmini G; Aurilia C; Donati S; Brandi ML
Endocrine; 2023 Sep; 81(3):409-418. PubMed ID: 37160841
[TBL] [Abstract][Full Text] [Related]
25. Parathyroid cancer: An update.
Rodrigo JP; Hernandez-Prera JC; Randolph GW; Zafereo ME; Hartl DM; Silver CE; Suárez C; Owen RP; Bradford CR; Mäkitie AA; Shaha AR; Bishop JA; Rinaldo A; Ferlito A
Cancer Treat Rev; 2020 Jun; 86():102012. PubMed ID: 32247225
[TBL] [Abstract][Full Text] [Related]
26. Semi-quantitative analysis of
Zhang M; Sun L; Rui W; Guo R; He H; Miao Y; Meng H; Liu J; Li B
Quant Imaging Med Surg; 2019 Aug; 9(8):1394-1401. PubMed ID: 31559168
[TBL] [Abstract][Full Text] [Related]
27. Parathyroid Carcinoma.
Cetani F; Pardi E; Marcocci C
Front Horm Res; 2019; 51():63-76. PubMed ID: 30641523
[TBL] [Abstract][Full Text] [Related]
28. Parathyroid carcinoma.
Salcuni AS; Cetani F; Guarnieri V; Nicastro V; Romagnoli E; de Martino D; Scillitani A; Cole DEC
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):877-889. PubMed ID: 30551989
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Performance of F-18 Fluorocholine PET/CT for Parathyroid Localization in Hyperparathyroidism: a Systematic Review and Meta-Analysis.
Kim SJ; Lee SW; Jeong SY; Pak K; Kim K
Horm Cancer; 2018 Dec; 9(6):440-447. PubMed ID: 30121878
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid carcinoma: a clinical and genetic perspective.
Cetani F; Pardi E; Marcocci C
Minerva Endocrinol; 2018 Jun; 43(2):144-155. PubMed ID: 28949121
[TBL] [Abstract][Full Text] [Related]
31. Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years.
Christakis I; Silva AM; Williams MD; Garden A; Grubbs EG; Busaidy NL; Lee JE; Perrier ND; Zafereo M
Pract Radiat Oncol; 2017; 7(6):e463-e470. PubMed ID: 28751227
[TBL] [Abstract][Full Text] [Related]
32. A nationwide study on parathyroid carcinoma.
Ryhänen EM; Leijon H; Metso S; Eloranta E; Korsoff P; Ahtiainen P; Kekäläinen P; Tamminen M; Ristamäki R; Knutar O; Löyttyniemi E; Niskanen L; Väisänen M; Heiskanen I; Välimäki MJ; Laakso M; Haglund C; Arola J; Schalin-Jäntti C
Acta Oncol; 2017 Jul; 56(7):991-1003. PubMed ID: 28362521
[TBL] [Abstract][Full Text] [Related]
33. [Parathyroid cancer].
Ságová I; Stančík M; Kentoš P; Pavai D; Kantárová D; Vaňuga A; Vaňuga P
Vnitr Lek; 2017; 63(2):139-144. PubMed ID: 28334546
[TBL] [Abstract][Full Text] [Related]
34. Association of parathyroid carcinoma and thyroid disorders: A clinical review.
Campennì A; Giovinazzo S; Pignata SA; Di Mauro F; Santoro D; Curtò L; Trimarchi F; Ruggeri RM; Baldari S
Endocrine; 2017 Apr; 56(1):19-26. PubMed ID: 27744598
[TBL] [Abstract][Full Text] [Related]
35. A nonfunctioning parathyroid carcinoma misdiagnosed as a follicular thyroid nodule.
Cetani F; Frustaci G; Torregrossa L; Magno S; Basolo F; Campomori A; Miccoli P; Marcocci C
World J Surg Oncol; 2015 Sep; 13():270. PubMed ID: 26350418
[TBL] [Abstract][Full Text] [Related]
36. Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).
Lastoria S; Marciello F; Faggiano A; Aloj L; Caracò C; Aurilio M; D'Ambrosio L; Di Gennaro F; Ramundo V; Camera L; De Luca L; Fonti R; Napolitano V; Colao A
Endocrine; 2016 Jun; 52(3):488-94. PubMed ID: 26242621
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid carcinoma in more than 1,000 patients: A population-level analysis.
Sadler C; Gow KW; Beierle EA; Doski JJ; Langer M; Nuchtern JG; Vasudevan SA; Goldfarb M
Surgery; 2014 Dec; 156(6):1622-9; discussion 1629-30. PubMed ID: 25456964
[TBL] [Abstract][Full Text] [Related]
38. 11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.
Braeuning U; Pfannenberg C; Gallwitz B; Teichmann R; Mueller M; Dittmann H; Reimold M; Bares R
Nuklearmedizin; 2015; 54(1):26-30. PubMed ID: 25427653
[TBL] [Abstract][Full Text] [Related]
39. Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials.
Qi WX; Tang LN; He AN; Yao Y; Shen Z
Int J Clin Oncol; 2014 Apr; 19(2):403-10. PubMed ID: 23605142
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and management of parathyroid cancer.
Schulte KM; Talat N
Nat Rev Endocrinol; 2012 Oct; 8(10):612-22. PubMed ID: 22751344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
